Who can use Inbruja(Levodopa)?

It is indicated for patients with unresectable or metastatic liposarcoma or leiomyosarcoma who have previously received anthracycline-based chemotherapy.

Trabectedin for Injection is a chemotherapeutic agent used in the treatment of certain cancers, particularly soft tissue sarcoma and ovarian cancer. The drug is designed to interfere with DNA transcription and repair in cancer cells. By binding to the minor groove of DNA, Trabectedin induces cell cycle arrest and apoptosis. Trabectedin is currently tentatively approved by the FDA, pending the expiration of relevant patent protections and the resolution of ongoing patent litigation. It is administered intravenously, typically over 24 hours, in cycles.